McKesson Corporation (LON:0JZU)
782.10
-1.00 (-0.13%)
At close: Oct 15, 2025
McKesson Employees
As of March 31, 2025, McKesson had 45,000 total employees, including 43,000 full-time and 2,000 part-time employees. The number of employees decreased by 6,000 or -11.76% compared to the previous year.
Employees
45,000
Change (1Y)
-6,000
Growth (1Y)
-11.76%
Revenue / Employee
6.26M GBP
Profits / Employee
52.49K GBP
Market Cap
73.53B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 45,000 | -6,000 | -11.76% |
Mar 31, 2024 | 51,000 | 0 | - |
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
McKesson News
- 5 days ago - McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity - Seeking Alpha
- 5 days ago - Here's How Much You Would Have Made Owning McKesson Stock In The Last 10 Years - Benzinga
- 6 days ago - Guru Fundamental Report for MCK - Nasdaq
- 7 days ago - McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio - Nasdaq
- 9 days ago - Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report? - Nasdaq
- 13 days ago - McKesson (MCK) Achieves High Rating Amidst Healthcare Sector Fluctuations - GuruFocus
- 15 days ago - See How McKesson Shares Rise with Money Flows - FX Empire
- 19 days ago - Noteworthy ETF Outflows: USMV, MCK, MSI, RSG - Nasdaq